Form 4: Phreesia SVP David Linetsky Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
David Linetsky, SVP of Life Sciences at Phreesia, Inc., sold shares of common stock to cover tax withholding obligations related to the settlement of performance-based restricted stock units.
Summary
- David Linetsky, SVP of Life Sciences at Phreesia, Inc., reported the sale of Phreesia common stock on January 27, 2025.
- The sales were executed to cover tax withholding obligations related to the settlement of performance-based restricted stock units.
- A total of 8,158 shares were sold at a weighted average price of $27.1848, with individual prices ranging from $26.75 to $27.74.
- An additional 3,527 shares were sold at a weighted average price of $28.1505, with individual prices ranging from $27.75 to $28.39.
- Following the transactions, Linetsky directly owns 231,271 shares and indirectly owns 8,851 shares through his spouse.
Sentiment
Score: 5
Explanation: The document reflects a routine transaction (stock sale for tax obligations) by a company executive, with no indication of positive or negative sentiment towards the company's prospects.
Industry Context
Form 4 filings are a routine part of the US stock market, providing transparency into the transactions of company insiders. These filings are closely watched by investors seeking insights into management's perspective on the company's stock.
Key Dates
| Date | Description |
|---|---|
| 01/27/2025 | Date of stock sale transactions. |
| 01/29/2025 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.